Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-48,744
Closed -$1.86M 2862
2025
Q1
$1.86M Buy
48,744
+42,536
+685% +$1.8M 0.01% 835
2024
Q4
$272K Buy
+6,208
New +$273K ﹤0.01% 1770
2024
Q2
Sell
-51,834
Closed -$3.24M 2438
2024
Q1
$3.24M Buy
51,834
+3,749
+8% +$224K 0.02% 397
2023
Q4
$2.69M Buy
+48,085
New +$2.4M 0.02% 527
2023
Q3
Sell
-10,223
Closed -$655K 2573
2023
Q2
$655K Buy
+10,223
New +$582K 0.01% 1210
2021
Q1
Sell
-4,787
Closed -$315K 2798
2020
Q4
$315K Buy
+4,787
New +$280K 0.01% 1260
2019
Q4
Sell
-39,990
Closed -$2M 1275
2019
Q3
$2M Buy
+39,990
New +$1.89M 0.09% 169

Other funds holding ENOV

HRT Financial's ENOV Position: Q2 2025 in Review

HRT Financial sold out of Enovis (ENOV) in Q2 2025, closing a stake of 48,744 shares — an estimated $1.86M sold.

HRT Financial first reported a position in ENOV in Q3 2019 and held it in 7 quarters. The position peaked at $3.24M in Q1 2024. 285 funds tracked by Wall St. Rank hold ENOV as of Q2 2025.

  • HRT Financial reported no remaining Enovis position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 48,744 Enovis shares in Q2 2025, an estimated $1.86M.
  • HRT Financial first reported a position in Enovis in Q3 2019 and held it in 7 quarters.
  • HRT Financial's Enovis position peaked at $3.24M in Q1 2024.
  • 285 funds tracked by Wall St. Rank held Enovis as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.